Lab-grown early extra-embyronic cells to study cell fate regulation
Within a few days of fertilisation, the cells of an embryo can take either of two paths; form the embryo itself, or be in the group that becomes the placenta and yolk sac. As a cell journeys further down a particular path, its options become more limited. Usually, it’s particularly difficult to cross between paths, but the early embryo has a group of ‘backup’ cells that for only a small window could join either path and compensate for any changes. We know very little about these intermediate cells, but now researchers have found a way to grow them in the lab. These intermediate cells assemble into ‘artificial blastocysts’, spheres called blastoids (top row enlarging over 4 days, and ‘sliced’ through, bottom row) providing a new way to study in detail this mysterious stage of how embryos' options are kept open for as long as possible.
This study was in collaboration with the MRC London Institute of Medical Sciences' Developmental Epigenomics group
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.